Clinical Trial Update: A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours [Phase 1]

View source ↗

Summary

Phase I clinical study of HLX3902 in metastatic castration-resistant prostate cancer and other advanced/metastatic solid tumors; the trial status is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Solid Tumors

Drugs mentioned

• HLX3902

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: mCRPC or Advanced/Metastatic Solid Tumors | Phase 1 | Status: NOT_YET_RECRUITING